companydata.dkcompanydata.dk

NEUROLOGISK KLINIK ApS: Financial statements 2018

CVR: 31748429

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

NEUROLOGISK KLINIK ApS (CVR 31748429) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 89,099 and a net result of DKK 13,197 compared with DKK 100,395 the year before. That is a decrease of 55.8% compared with the year before. Equity in the 2018 report amounted to DKK 375,994. The solvency ratio was 58%.

Gross Profit
DKK 89,099
Profit/Loss
DKK 13,197
Equity
DKK 375,994
Total Assets
DKK 647,717
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018-89K13K376K0
2017-202K100K363K0
2016-112K30K262K-
2015-157K63K233K-
2014308K262K192K419K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

NEUROLOGISK KLINIK ApS: The 2017 annual report is outJun 4, 2018

NEUROLOGISK KLINIK ApS has published its annual report for 2017. Gross profit came to DKK 201,725, and the net result was DKK 100,395.

About NEUROLOGISK KLINIK ApS

NEUROLOGISK KLINIK ApS was a Danish company of the type Anpartsselskab based in Langå, founded in 2008. The company has been dissolved on 19 December 2023. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SOMNOLEPSION BIOTECH ApS. The company has 0 employees (2020). In 2022, the company reported a gross profit of DKK 99,955 and a net result of DKK 265,911 compared with DKK 699,794 the year before. Equity in the 2022 report amounted to DKK 1,716,091.

Source: annual report 2022, Danish Business Authority